Hospital-based Surveillance of Rotavirus Gastroenteritis in Young Taiwanese Children
NCT03550937 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5040
Last updated 2018-06-18
Summary
Rotavirus remains among the leading causes of pediatric gastroenteritis requiring hospitalization in the world. Surveillance studies revealed that more than 90% of the global circulating rotavirus strains were predominated by several major genotypes. Clinical trials and post-marketing studies have demonstrated that the currently available rotavirus vaccine can provide sufficient protection against strains of the prevalent genotypes. However, the emerging strains with new genotypes were increasingly reported in the past decade, an ongoing surveillance of the strain changes is needed in the regions where the pediatric population is either fully or partly immunized. In this project, the investigators will setup a hospital-based gastroenteritis surveillance network by incorporating 8 major hospitals in northern, central, southern and eastern Taiwan. From 2013 to 2015, children aged 5 years or younger hospitalized to one of the 8 sentinel hospitals due to acute gastroenteritis will be screened for rotavirus infection, and viral proteins 7 \[VP7\] (G type) and viral proteins 4 \[VP4\] (P type) genotypes of rotavirus will be determined for each infected case. The demographics and clinical manifestations of study subjects will also be collected and analyzed. Through this project, the investigators will be able to detect emerging genotypes of rotavirus and delineate the strain distribution during the two years of study in Taiwan. The investigators can also have more comprehensive understanding of the epidemiology of rotavirus regarding to the incidence, disease characteristics, temporal and geographic variations of severe rotavirus gastroenteritis in Taiwanese children. Results from this project will provide valuable information for future implementation of mass immunization against rotavirus in Taiwan.
Conditions
- Rotavirus Gastroenteritis, Young Taiwanese Children
Sponsors & Collaborators
-
National Taiwan University Hospital
lead OTHER
Eligibility
- Max Age
- 5 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-12-11
- Primary Completion
- 2018-02-06
- Completion
- 2018-02-06
Countries
- Taiwan
Study Locations
More Related Trials
-
The Antiviral Therapy in Pregnant Women to Reduce Mother-to-infant Transmission of Hepatitis B Virus-drug Test
NCT01312012 ·Status: UNKNOWN ·Phase: PHASE4
-
Study on Dynamic Changes of the Maternal Anti-EV71 and Anti-CVA16 Antibody Levels in Infants and Young Children
NCT01255124 ·Status: COMPLETED
-
Efficacy of Hepatitis B Vaccine Boosters Among Neonatally Vaccinated Children in Chongqing
NCT03867643 ·Status: RECRUITING
-
Evaluation of Immunoprotection Provided by Hepatitis B Vaccine After Birth in Healthy Children
NCT04439435 ·Status: UNKNOWN
-
Nation-wide Hepatitis C Virus (HCV) Registry in Taiwan
NCT03200379 ·Status: RECRUITING
-
Prevention of Hepatitis B Virus Mother-to-child Transmission by Serovaccination.
NCT01810835 ·Status: COMPLETED
-
RSV in Acute Respiratory Infection Surveillance Among Community-Dwelling Elderly Aged ≥50 Years in China
NCT07075029 ·Status: NOT_YET_RECRUITING
-
An Observational Study of Hepatitis C Virus in Pregnancy
NCT01959321 ·Status: COMPLETED
-
Immunogenicity Study of an Inactivated Hepatitis A Vaccine in Infants and Young Children
NCT00139113 ·Status: COMPLETED ·Phase: PHASE4
-
Neonatal Vaccination Against Hepatitis B in Africa - Sero-survey in Senegal
NCT03829735 ·Status: WITHDRAWN ·Phase: NA
-
The Hepatitis B Vaccine Booster Response Among the Youth Who Had Completed Neonatal Hepatitis B Vaccines
NCT00792610 ·Status: COMPLETED ·Phase: NA
-
Mother-to-child Transmission of HBV in China
NCT05172453 ·Status: RECRUITING
-
Seroprevalence of Hepatitis B Infection and Effect of Booster Response Amongst Taiwanese Young Adults
NCT00702663 ·Status: UNKNOWN
-
Hepatitis E Virus Infection in Pediatric Transplantation, a Prevalence Study
NCT02809885 ·Status: UNKNOWN ·Phase: NA
-
The Immune Responses After Hepatitis B Revaccination Doses in a Young Cohort
NCT04970836 ·Status: RECRUITING ·Phase: NA
-
Study on Gut Microbiota in Chronic HBV Infected Patients
NCT03587467 ·Status: UNKNOWN
-
Long-term Effectiveness of a Recombinant Hepatitis E Vaccine
NCT05976594 ·Status: UNKNOWN
-
Clinical Study on the Effect of IVF-ET on Mother-to-child Transmission of Hepatitis B Virus
NCT03932851 ·Status: UNKNOWN
-
Investigation of Hepatitis B and Hepatitis C in Taiwan
NCT00946010 ·Status: COMPLETED
-
Evaluation of Paternal, Maternal and Obstetric Factors Leading to the Hepatitis B Immunization Failure in Hong Kong
NCT02443233 ·Status: COMPLETED
-
Maternal Antiviral Treatment and Infants Immunoprophylaxis in the Prevention of Mother-to-child Transmission
NCT03977987 ·Status: COMPLETED
-
Seroepidemiology of Viral Hepatitis in Hong Kong
NCT04371276 ·Status: COMPLETED
-
Comparative Immunogenicity Study of Two Hepatitis A Vaccines
NCT03231605 ·Status: UNKNOWN ·Phase: PHASE4
-
Role of Cytokines in Hepatitis E Virus Infection During Pregnancy
NCT01062321 ·Status: COMPLETED
-
A Study of the Interruption on the Mother-to-child Transmission of Hepatitis B Virus (HBV MTCT)in Newborns at High Risk
NCT02901418 ·Status: UNKNOWN